A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat - PubMed (original) (raw)
A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat
M J Reed et al. Metabolism. 2000 Nov.
Abstract
This study was initiated to develop an animal model of type 2 diabetes in a non-obese, outbred rat strain that replicates the natural history and metabolic characteristics of the human syndrome and is suitable for pharmaceutical research. Male Sprague-Dawley rats (n = 31), 7 weeks old, were fed normal chow (12% of calories as fat), or high-fat diet (40% of calories as fat) for 2 weeks and then injected with streptozotocin (STZ, 50 mg/kg intravenously). Before STZ injection, fat-fed rats had similar glucose concentrations to chow-fed rats, but significantly higher insulin, free fatty acid (FFA), and triglyceride (TG) concentrations (P < .01 to .0001). Plasma insulin concentrations in response to oral glucose (2 g/kg) were increased 2-fold by fat feeding (P < .01), and adipocyte glucose clearance under maximal insulin stimulation was significantly reduced (P < .001), suggesting that fat feeding induced insulin resistance. STZ injection increased glucose (P < .05), insulin (P < .05), FFA (P < .05), and TG (P < .0001) concentrations in fat-fed rats (Fat-fed/STZ rats) compared with chow-fed, STZ-injected rats (Chow-fed/STZ rats). Fat-fed/STZ rats were not insulin deficient compared with normal chow-fed rats, but had hyperglycemia and a somewhat higher insulin response to an oral glucose challenge (both P < .05). In addition, insulin-stimulated adipocyte glucose clearance was reduced in Fat-fed/STZ rats compared with both chow-fed and Chow-fed/STZ rats (P < .001). Finally, Fat-fed/STZ rats were sensitive to the glucose lowering effects of metformin and troglitazone. In conclusion, Fat-fed/STZ rats provide a novel animal model for type 2 diabetes, simulates the human syndrome, and is suitable for the testing of antidiabetic compounds.
Similar articles
- Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Brignetti D, Luo J, Khandwala A, Reaven GM. Reed MJ, et al. Diabetologia. 1999 Jan;42(1):102-6. doi: 10.1007/s001250051121. Diabetologia. 1999. PMID: 10027587 - Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ, Mroz Z, Dekker R, Corbijn H, Ackermans M, Sauerwein H. Koopmans SJ, et al. Metabolism. 2006 Jul;55(7):960-71. doi: 10.1016/j.metabol.2006.03.004. Metabolism. 2006. PMID: 16784971 - Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Srinivasan K, et al. Pharmacol Res. 2005 Oct;52(4):313-20. doi: 10.1016/j.phrs.2005.05.004. Pharmacol Res. 2005. PMID: 15979893 - The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin.
Portha B, Blondel O, Serradas P, McEvoy R, Giroix MH, Kergoat M, Bailbe D. Portha B, et al. Diabete Metab. 1989 Mar-Apr;15(2):61-75. Diabete Metab. 1989. PMID: 2525491 Review. - Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics.
Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, Agrawal YO. Goyal SN, et al. Chem Biol Interact. 2016 Jan 25;244:49-63. doi: 10.1016/j.cbi.2015.11.032. Epub 2015 Dec 2. Chem Biol Interact. 2016. PMID: 26656244 Review.
Cited by
- Preconception Alcohol Exposure Increases the Susceptibility to Diabetes in the Offspring.
Al-Yasari A, Jabbar S, Cabrera MA, Rousseau B, Sarkar DK. Al-Yasari A, et al. Endocrinology. 2021 Jan 1;162(1):bqaa188. doi: 10.1210/endocr/bqaa188. Endocrinology. 2021. PMID: 33057655 Free PMC article. - Metformin enhances the osteogenic activity of rat bone marrow mesenchymal stem cells by inhibiting oxidative stress induced by diabetes mellitus: an in vitro and in vivo study.
Dong K, Zhou WJ, Liu ZH. Dong K, et al. J Periodontal Implant Sci. 2023 Feb;53(1):54-68. doi: 10.5051/jpis.2106240312. Epub 2022 Aug 29. J Periodontal Implant Sci. 2023. PMID: 36468474 Free PMC article. - A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma.
Jeong BK, Choi WI, Choi W, Moon J, Lee WH, Choi C, Choi IY, Lee SH, Kim JK, Ju YS, Kim P, Moon YA, Park JY, Kim H. Jeong BK, et al. Nat Commun. 2024 Aug 2;15(1):6506. doi: 10.1038/s41467-024-50660-y. Nat Commun. 2024. PMID: 39090079 Free PMC article. - Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats.
Davidson EP, Coppey LJ, Shevalye H, Obrosov A, Yorek MA. Davidson EP, et al. J Diabetes Res. 2018 Jul 2;2018:2967127. doi: 10.1155/2018/2967127. eCollection 2018. J Diabetes Res. 2018. PMID: 30057911 Free PMC article. - Novel High-Fat Diet Formulation and Streptozotocin Treatment for Induction of Prediabetes and Type 2 Diabetes in Rats.
Vatandoust N, Rami F, Salehi AR, Khosravi S, Dashti G, Eslami G, Momenzadeh S, Salehi R. Vatandoust N, et al. Adv Biomed Res. 2018 Jul 2;7:107. doi: 10.4103/abr.abr_8_17. eCollection 2018. Adv Biomed Res. 2018. PMID: 30069438 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous